Literature DB >> 8970901

The renal clearance of free and conjugated pyridinium cross-links of collagen.

A Colwell1, R Eastell.   

Abstract

We developed a sensitive reversed-phase high performance liquid chromatography (HPLC) assay to measure free and total Pyridinoline (Pyr) and Deoxypyridinoline (Dpyr) in serum. The method was used to measure total serum levels in seven premenopausal women (ages 52.2 +/- 2.4 years) and to investigate the renal clearance of free and conjugated Pyr and Dpyr in two groups of children (group 1: 13 girls, ages 11-13 years; group 2: 18 older children [2 male, 16 female], ages 13-18 years). Blood and 24-h urine samples were collected from the younger group to measure the renal clearance, and blood and 2-h morning urine samples from the older group were collected to investigate the fractional clearance. Total Pyr and Dpyr in the premenopausal women was 4.08 +/- 0.91 and 1.18 +/- 0.39 nmol/l, respectively. Free and total Pyr and Dpyr in serum and urine was elevated in both groups of children. The free serum levels were 16 and 18% in young and older children, respectively, compared with 40 and 46% in the urine. The percentage of free Dpyr in serum decreased with total urinary Pyr excretion (r = -0.56, p < 0.005, n = 31). The renal clearance of the free cross-link fraction in both groups was 4-fold higher than the conjugated fraction. The fractional clearance of the free fraction was greater than 1 (p < 0.001) and the conjugated fraction less than 1 (p < 0.001). The fractional excretion of free Dpyr increased with total urinary Pyr excretion (r = 0.66, p < 0.005, n = 13). We conclude that HPLC can be used to measure free and total Pyr and Dpyr in serum and that some free Pyr and Dpyr excreted in urine is produced by the kidney.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970901     DOI: 10.1002/jbmr.5650111220

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.

Authors:  C Heuck; L Heickendorff; O D Wolthers
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

2.  How do bisphosphonates prevent fractures?

Authors:  J H Tobias
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

3.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 4.  Biochemical assessment of bone turnover and bone fragility in men.

Authors:  P Szulc; J M Kaufman; P D Delmas
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

Review 5.  Inside the "fragile" infant: pathophysiology, molecular background, risk factors and investigation of neonatal osteopenia.

Authors:  Charalampos Dokos; Christos Tsakalidis; Athanasios Tragiannidis; Dimitrios Rallis
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05

6.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.